Endometrial Cancer Market Size, Share, Trends, Growth and Forecast 2034

Endometrial Cancer Market

Endometrial Cancer Market By Type of Cancer (Uterine Sarcomas, Endometrial Carcinoma, and Others), By Type of Therapy (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapies, and Others), By Diagnosis Method (Pelvic Ultrasound, Biopsy, CT Scan Hysteroscopy, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Healthcare Report Format : PDF Pages: 228 Report Code: ZMR-10600 Published Date: May-2026 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 31.09 Billion USD 51.15 Billion 5.60% 2024

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Endometrial Cancer Market, (2025 - 2034) (USD Billion)
    • 2.2 Global Endometrial Cancer Market : snapshot
  • Chapter 3. Global Endometrial Cancer Market - Industry Analysis
    • 3.1 Endometrial Cancer Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Ongoing investments in cancer research and increased healthcare expenditure will fuel market expansion
    • 3.3 Market Restraints
      • 3.3.1. High treatment costs shape the endometrial cancer market during the forecast period
    • 3.4 Market Opportunities
      • 3.4.1. Technological advancements to improve diagnostic procedures will create growth opportunities
    • 3.5 Market Challenges
      • 3.5.1. The prominent challenges affecting the endometrial cancer industry
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Type of Cancer
      • 3.7.2 Market attractiveness analysis By Type of Therapy
      • 3.7.3 Market attractiveness analysis By Diagnosis Method
  • Chapter 4. Global Endometrial Cancer Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Endometrial Cancer Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Endometrial Cancer Market - Type of Cancer Analysis
    • 5.1 Global Endometrial Cancer Market overview: By Type of Cancer
      • 5.1.1 Global Endometrial Cancer Market share, By Type of Cancer, 2024 and 2034
    • 5.2 Uterine Sarcomas
      • 5.2.1 Global Endometrial Cancer Market by Uterine Sarcomas, 2025 - 2034 (USD Billion)
    • 5.3 Endometrial Carcinoma
      • 5.3.1 Global Endometrial Cancer Market by Endometrial Carcinoma, 2025 - 2034 (USD Billion)
    • 5.4 Others
      • 5.4.1 Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • Chapter 6. Global Endometrial Cancer Market - Type of Therapy Analysis
    • 6.1 Global Endometrial Cancer Market overview: By Type of Therapy
      • 6.1.1 Global Endometrial Cancer Market share, By Type of Therapy, 2024 and 2034
    • 6.2 Chemotherapy
      • 6.2.1 Global Endometrial Cancer Market by Chemotherapy, 2025 - 2034 (USD Billion)
    • 6.3 Radiation Therapy
      • 6.3.1 Global Endometrial Cancer Market by Radiation Therapy, 2025 - 2034 (USD Billion)
    • 6.4 Immunotherapy
      • 6.4.1 Global Endometrial Cancer Market by Immunotherapy, 2025 - 2034 (USD Billion)
    • 6.5 Targeted Therapies
      • 6.5.1 Global Endometrial Cancer Market by Targeted Therapies, 2025 - 2034 (USD Billion)
    • 6.6 Others
      • 6.6.1 Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • Chapter 7. Global Endometrial Cancer Market - Diagnosis Method Analysis
    • 7.1 Global Endometrial Cancer Market overview: By Diagnosis Method
      • 7.1.1 Global Endometrial Cancer Market share, By Diagnosis Method, 2024 and 2034
    • 7.2 Pelvic Ultrasound
      • 7.2.1 Global Endometrial Cancer Market by Pelvic Ultrasound, 2025 - 2034 (USD Billion)
    • 7.3 Biopsy
      • 7.3.1 Global Endometrial Cancer Market by Biopsy, 2025 - 2034 (USD Billion)
    • 7.4 CT Scan Hysteroscopy
      • 7.4.1 Global Endometrial Cancer Market by CT Scan Hysteroscopy, 2025 - 2034 (USD Billion)
    • 7.5 Others
      • 7.5.1 Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • Chapter 8. Endometrial Cancer Market - Regional Analysis
    • 8.1 Global Endometrial Cancer Market Regional Overview
    • 8.2 Global Endometrial Cancer Market Share, by Region, 2024 & 2034 (USD Billion)
    • 8.3. North America
      • 8.3.1 North America Endometrial Cancer Market, 2025 - 2034 (USD Billion)
        • 8.3.1.1 North America Endometrial Cancer Market, by Country, 2025 - 2034 (USD Billion)
    • 8.4 North America Endometrial Cancer Market, by Type of Cancer, 2025 - 2034
      • 8.4.1 North America Endometrial Cancer Market, by Type of Cancer, 2025 - 2034 (USD Billion)
    • 8.5 North America Endometrial Cancer Market, by Type of Therapy, 2025 - 2034
      • 8.5.1 North America Endometrial Cancer Market, by Type of Therapy, 2025 - 2034 (USD Billion)
    • 8.6 North America Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034
      • 8.6.1 North America Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034 (USD Billion)
    • 8.4. Europe
      • 8.4.2 Europe Endometrial Cancer Market, 2025 - 2034 (USD Billion)
        • 8.4.2.1 Europe Endometrial Cancer Market, by Country, 2025 - 2034 (USD Billion)
    • 8.4 Europe Endometrial Cancer Market, by Type of Cancer, 2025 - 2034
      • 8.4.1 Europe Endometrial Cancer Market, by Type of Cancer, 2025 - 2034 (USD Billion)
    • 8.5 Europe Endometrial Cancer Market, by Type of Therapy, 2025 - 2034
      • 8.5.1 Europe Endometrial Cancer Market, by Type of Therapy, 2025 - 2034 (USD Billion)
    • 8.6 Europe Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034
      • 8.6.1 Europe Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034 (USD Billion)
    • 8.5. Asia Pacific
      • 8.5.3 Asia Pacific Endometrial Cancer Market, 2025 - 2034 (USD Billion)
        • 8.5.3.1 Asia Pacific Endometrial Cancer Market, by Country, 2025 - 2034 (USD Billion)
    • 8.4 Asia Pacific Endometrial Cancer Market, by Type of Cancer, 2025 - 2034
      • 8.4.1 Asia Pacific Endometrial Cancer Market, by Type of Cancer, 2025 - 2034 (USD Billion)
    • 8.5 Asia Pacific Endometrial Cancer Market, by Type of Therapy, 2025 - 2034
      • 8.5.1 Asia Pacific Endometrial Cancer Market, by Type of Therapy, 2025 - 2034 (USD Billion)
    • 8.6 Asia Pacific Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034
      • 8.6.1 Asia Pacific Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034 (USD Billion)
    • 8.6. Latin America
      • 8.6.4 Latin America Endometrial Cancer Market, 2025 - 2034 (USD Billion)
        • 8.6.4.1 Latin America Endometrial Cancer Market, by Country, 2025 - 2034 (USD Billion)
    • 8.4 Latin America Endometrial Cancer Market, by Type of Cancer, 2025 - 2034
      • 8.4.1 Latin America Endometrial Cancer Market, by Type of Cancer, 2025 - 2034 (USD Billion)
    • 8.5 Latin America Endometrial Cancer Market, by Type of Therapy, 2025 - 2034
      • 8.5.1 Latin America Endometrial Cancer Market, by Type of Therapy, 2025 - 2034 (USD Billion)
    • 8.6 Latin America Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034
      • 8.6.1 Latin America Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034 (USD Billion)
    • 8.7. The Middle-East and Africa
      • 8.7.5 The Middle-East and Africa Endometrial Cancer Market, 2025 - 2034 (USD Billion)
        • 8.7.5.1 The Middle-East and Africa Endometrial Cancer Market, by Country, 2025 - 2034 (USD Billion)
    • 8.4 The Middle-East and Africa Endometrial Cancer Market, by Type of Cancer, 2025 - 2034
      • 8.4.1 The Middle-East and Africa Endometrial Cancer Market, by Type of Cancer, 2025 - 2034 (USD Billion)
    • 8.5 The Middle-East and Africa Endometrial Cancer Market, by Type of Therapy, 2025 - 2034
      • 8.5.1 The Middle-East and Africa Endometrial Cancer Market, by Type of Therapy, 2025 - 2034 (USD Billion)
    • 8.6 The Middle-East and Africa Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034
      • 8.6.1 The Middle-East and Africa Endometrial Cancer Market, by Diagnosis Method, 2025 - 2034 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1 Johnson & Johnson
      • 9.1.1 Overview
      • 9.1.2 Financials
      • 9.1.3 Product Portfolio
      • 9.1.4 Business Strategy
      • 9.1.5 Recent Developments
    • 9.2 Bristol Myers Squibb
      • 9.2.1 Overview
      • 9.2.2 Financials
      • 9.2.3 Product Portfolio
      • 9.2.4 Business Strategy
      • 9.2.5 Recent Developments
    • 9.3 Pfizer
      • 9.3.1 Overview
      • 9.3.2 Financials
      • 9.3.3 Product Portfolio
      • 9.3.4 Business Strategy
      • 9.3.5 Recent Developments
    • 9.4 Roche
      • 9.4.1 Overview
      • 9.4.2 Financials
      • 9.4.3 Product Portfolio
      • 9.4.4 Business Strategy
      • 9.4.5 Recent Developments
    • 9.5 Novartis
      • 9.5.1 Overview
      • 9.5.2 Financials
      • 9.5.3 Product Portfolio
      • 9.5.4 Business Strategy
      • 9.5.5 Recent Developments
    • 9.6 AbbVie
      • 9.6.1 Overview
      • 9.6.2 Financials
      • 9.6.3 Product Portfolio
      • 9.6.4 Business Strategy
      • 9.6.5 Recent Developments
    • 9.7 Takeda Pharmaceutical Company
      • 9.7.1 Overview
      • 9.7.2 Financials
      • 9.7.3 Product Portfolio
      • 9.7.4 Business Strategy
      • 9.7.5 Recent Developments
    • 9.8 Gilead Sciences
      • 9.8.1 Overview
      • 9.8.2 Financials
      • 9.8.3 Product Portfolio
      • 9.8.4 Business Strategy
      • 9.8.5 Recent Developments
    • 9.9 Merck & Co.
      • 9.9.1 Overview
      • 9.9.2 Financials
      • 9.9.3 Product Portfolio
      • 9.9.4 Business Strategy
      • 9.9.5 Recent Developments
    • 9.10 GlaxoSmithKline
      • 9.10.1 Overview
      • 9.10.2 Financials
      • 9.10.3 Product Portfolio
      • 9.10.4 Business Strategy
      • 9.10.5 Recent Developments
    • 9.11 Amgen
      • 9.11.1 Overview
      • 9.11.2 Financials
      • 9.11.3 Product Portfolio
      • 9.11.4 Business Strategy
      • 9.11.5 Recent Developments
    • 9.12 Sanofi
      • 9.12.1 Overview
      • 9.12.2 Financials
      • 9.12.3 Product Portfolio
      • 9.12.4 Business Strategy
      • 9.12.5 Recent Developments
    • 9.13 AstraZeneca
      • 9.13.1 Overview
      • 9.13.2 Financials
      • 9.13.3 Product Portfolio
      • 9.13.4 Business Strategy
      • 9.13.5 Recent Developments
    • 9.14 BeiGene
      • 9.14.1 Overview
      • 9.14.2 Financials
      • 9.14.3 Product Portfolio
      • 9.14.4 Business Strategy
      • 9.14.5 Recent Developments
    • 9.15 Eli Lilly and Company
      • 9.15.1 Overview
      • 9.15.2 Financials
      • 9.15.3 Product Portfolio
      • 9.15.4 Business Strategy
      • 9.15.5 Recent Developments
    • 9.16 and others.
      • 9.16.1 Overview
      • 9.16.2 Financials
      • 9.16.3 Product Portfolio
      • 9.16.4 Business Strategy
      • 9.16.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Endometrial Cancer Market, 2025 - 2034 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Endometrial Cancer Market attractiveness, By Type of Cancer
  • 6. Global Endometrial Cancer Market attractiveness, By Type of Therapy
  • 7. Global Endometrial Cancer Market attractiveness, By Diagnosis Method
  • 8. Global Endometrial Cancer Market share by Type of Cancer, 2025 and 2034 (USD Billion)
  • 9. Global Endometrial Cancer Market by Uterine Sarcomas, 2025 - 2034 (USD Billion)
  • 10. Global Endometrial Cancer Market by Endometrial Carcinoma, 2025 - 2034 (USD Billion)
  • 11. Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • 12. Global Endometrial Cancer Market share by Type of Therapy, 2025 and 2034 (USD Billion)
  • 13. Global Endometrial Cancer Market by Chemotherapy, 2025 - 2034 (USD Billion)
  • 14. Global Endometrial Cancer Market by Radiation Therapy, 2025 - 2034 (USD Billion)
  • 15. Global Endometrial Cancer Market by Immunotherapy, 2025 - 2034 (USD Billion)
  • 16. Global Endometrial Cancer Market by Targeted Therapies, 2025 - 2034 (USD Billion)
  • 17. Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • 18. Global Endometrial Cancer Market share by Diagnosis Method, 2025 and 2034 (USD Billion)
  • 19. Global Endometrial Cancer Market by Pelvic Ultrasound, 2025 - 2034 (USD Billion)
  • 20. Global Endometrial Cancer Market by Biopsy, 2025 - 2034 (USD Billion)
  • 21. Global Endometrial Cancer Market by CT Scan Hysteroscopy, 2025 - 2034 (USD Billion)
  • 22. Global Endometrial Cancer Market by Others, 2025 - 2034 (USD Billion)
  • 23. Global Endometrial Cancer Market share, by Region, 2025 and 2034
  • 24. North America Endometrial Cancer Market, 2025 - 2034 (USD Billion)
  • 25. Europe Endometrial Cancer Market, 2025 - 2034 (USD Billion)
  • 26. Asia Pacific Endometrial Cancer Market, 2025 - 2034 (USD Billion)
  • 27. Latin America Endometrial Cancer Market, 2025 - 2034 (USD Billion)
  • 28. The Middle-East and Africa Endometrial Cancer Market, 2025 - 2034 (USD Billion)

Table Of Tables

  • 1. Global Endometrial Cancer Market: Snapshot
  • 2. Drivers of the Endometrial Cancer Market: impact analysis
  • 3. North America Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 4. North America Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 5. North America Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 6. U.S. Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 7. U.S. Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 8. U.S. Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 9. Canada Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 10. Canada Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 11. Canada Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 12. Europe Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 13. Europe Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 14. Europe Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 15. Germany Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 16. Germany Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 17. Germany Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 18. France Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 19. France Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 20. France Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 21. U.K. Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 22. U.K. Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 23. U.K. Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 24. Italy Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 25. Italy Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 26. Italy Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 27. Spain Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 28. Spain Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 29. Spain Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 30. Rest of Europe Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 31. Rest of Europe Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 32. Rest of Europe Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 33. Asia Pacific Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 34. Asia Pacific Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 35. Asia Pacific Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 36. China Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 37. China Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 38. China Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 39. Japan Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 40. Japan Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 41. Japan Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 42. India Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 43. India Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 44. India Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 45. South Korea Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 46. South Korea Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 47. South Korea Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 48. South-East Asia Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 49. South-East Asia Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 50. South-East Asia Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 51. Rest of Asia Pacific Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 52. Rest of Asia Pacific Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 53. Rest of Asia Pacific Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 54. Latin America Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 55. Latin America Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 56. Latin America Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 57. Brazil Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 58. Brazil Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 59. Brazil Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 60. Mexico Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 61. Mexico Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 62. Mexico Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 63. Rest of Latin America Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 64. Rest of Latin America Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 65. Rest of Latin America Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 66. The Middle-East and Africa Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 67. The Middle-East and Africa Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 68. The Middle-East and Africa Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 69. GCC Countries Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 70. GCC Countries Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 71. GCC Countries Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 72. South Africa Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 73. South Africa Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 74. South Africa Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)
  • 75. Rest of Middle-East Africa Endometrial Cancer Market revenue, By Type of Cancer, 2025 - 2034 (USD Billion)
  • 76. Rest of Middle-East Africa Endometrial Cancer Market revenue, By Type of Therapy, 2025 - 2034 (USD Billion)
  • 77. Rest of Middle-East Africa Endometrial Cancer Market revenue, By Diagnosis Method, 2025 - 2034 (USD Billion)

Methodology

FrequentlyAsked Questions

Endometrial cancer is caused by abnormal growth of cells in the uterus. It is a reproductive organ where fetal development takes place.

The global endometrial cancer market is expected to be driven by the rising prevalence of the condition across the globe.

According to study, the global endometrial cancer market size was worth around USD 31.09 billion in 2024 and is predicted to grow to around USD 51.15 billion by 2034.

The CAGR value of endometrial cancer market is expected to be around 5.60% during 2025-2034.

The global endometrial cancer industry is anticipated to be challenged by lack of effective infrastructure, absence of comprehensive medical reimbursement policies, and limited patient awareness.

Shift away from chemotherapy and remote diagnosis and treatment are the emerging trends and innovations impacting the endometrial cancer market.

The global endometrial cancer market has performed well so far and will offer similar trends in the coming years.

Europe will contribute notably towards the endometrial cancer market value.

The global endometrial cancer market is led by players like Johnson & Johnson, Bristol Myers Squibb, Pfizer, Roche, Novartis, AbbVie, Takeda Pharmaceutical Company, Gilead Sciences, Merck & Co., GlaxoSmithKline, Amgen, Sanofi, AstraZeneca, BeiGene, and Eli Lilly and Company.

The report explores crucial aspects of the endometrial cancer market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Endometrial CancerPerspective:Key Insights:OverviewDynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisWhat are the latest key trends in the endometrial cancer market?The global endometrial cancer market is segmented as follows:

HappyClients